BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8924029)

  • 1. Is the cuneiform nucleus a critical component of the mesencephalic locomotor region? An examination of the effects of excitotoxic lesions of the cuneiform nucleus on spontaneous and nucleus accumbens induced locomotion.
    Allen LF; Inglis WL; Winn P
    Brain Res Bull; 1996; 41(4):201-10. PubMed ID: 8924029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation into the role of the pedunculopontine tegmental nucleus in the mediation of locomotion and orofacial stereotypy induced by d-amphetamine and apomorphine in the rat.
    Inglis WL; Allen LF; Whitelaw RB; Latimer MP; Brace HM; Winn P
    Neuroscience; 1994 Feb; 58(4):817-33. PubMed ID: 8190259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outflow from the nucleus accumbens to the pedunculopontine tegmental nucleus: a dissociation between locomotor activity and the acquisition of responding for conditioned reinforcement stimulated by d-amphetamine.
    Inglis WL; Dunbar JS; Winn P
    Neuroscience; 1994 Sep; 62(1):51-64. PubMed ID: 7816212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreases in rat locomotor activity as a result of changes in synaptic transmission to neurons within the mesencephalic locomotor region.
    Brudzynski SM; Wu M; Mogenson GJ
    Can J Physiol Pharmacol; 1993; 71(5-6):394-406. PubMed ID: 8402406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. II. Examination of eating and drinking, rotation, and reaching and grasping following unilateral ibotenate or quinolinate lesions.
    Dunbar JS; Hitchcock K; Latimer M; Rugg EL; Ward N; Winn P
    Brain Res; 1992 Sep; 589(2):194-206. PubMed ID: 1356593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural sensitisation to repeated d-amphetamine: effects of excitotoxic lesions of the pedunculopontine tegmental nucleus.
    Alderson HL; Faulconbridge LF; Gregory LP; Latimer MP; Winn P
    Neuroscience; 2003; 118(2):311-5. PubMed ID: 12699767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R; Winn P
    Behav Brain Res; 1992 Nov; 51(2):127-37. PubMed ID: 1466779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitotoxic lesions of the prefrontal cortex attenuate the potentiation of amphetamine-induced locomotion by repeated neurotensin receptor activation.
    Blackburn A; Dewar K; Bauco P; Rompré PP
    Brain Res; 2004 Feb; 998(2):184-93. PubMed ID: 14751589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of locomotor activity induced by injections of carbachol into the tegmental pedunculopontine nucleus and adjacent areas in the rat.
    Brudzynski SM; Wu M; Mogenson GJ
    Brain Res; 1988 Jun; 451(1-2):119-25. PubMed ID: 3251577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction.
    Takakusaki K; Habaguchi T; Ohtinata-Sugimoto J; Saitoh K; Sakamoto T
    Neuroscience; 2003; 119(1):293-308. PubMed ID: 12763089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphetamine-induced hyperlocomotion in rats: Hippocampal modulation of the nucleus accumbens.
    White IM; Whitaker C; White W
    Hippocampus; 2006; 16(7):596-603. PubMed ID: 16763995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An examination of the effects of bilateral excitotoxic lesions of the pedunculopontine tegmental nucleus on responding to sucrose reward.
    Keating GL; Walker SC; Winn P
    Behav Brain Res; 2002 Aug; 134(1-2):217-28. PubMed ID: 12191808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomo-Functional Mapping of the Primate Mesencephalic Locomotor Region Using Stereotactic Lesions.
    Gay M; Belaid H; Rogers A; Pérez-García F; Roustan M; Bardinet E; François C; Karachi C
    Mov Disord; 2020 May; 35(5):789-799. PubMed ID: 31922282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of morphine in the nucleus accumbens on stimulant-induced locomotion.
    Layer RT; Uretsky NJ; Wallace LJ
    Pharmacol Biochem Behav; 1991 Sep; 40(1):21-6. PubMed ID: 1685784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM; Mogenson GJ
    Brain Res; 1985 May; 334(1):77-84. PubMed ID: 2986781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitotoxic lesions of the pedunculopontine differentially mediate morphine- and d-amphetamine-evoked striatal dopamine efflux and behaviors.
    Miller AD; Forster GL; Metcalf KM; Blaha CD
    Neuroscience; 2002; 111(2):351-62. PubMed ID: 11983320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area.
    Gillies DM; Mylecharane EJ; Jackson DM
    Eur J Pharmacol; 1996 May; 303(1-2):1-12. PubMed ID: 8804905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excitotoxic lesions of the pedunculopontine tegmental nucleus disinhibit orofacial behaviours stimulated by microinjections of d-amphetamine into rat ventrolateral caudate-putamen.
    Allen LF; Winn P
    Exp Brain Res; 1995; 104(2):262-74. PubMed ID: 7672019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the contributions of the pedunculopontine tegmental and cuneiform nuclei to anxiety and neophobia.
    Walker SC; Winn P
    Neuroscience; 2007 Dec; 150(2):273-90. PubMed ID: 17951012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrolytic lesions of the nucleus accumbens enhance locomotor sensitization to nicotine in rats.
    Kelsey JE; Willmore EJ
    Behav Neurosci; 2006 Jun; 120(3):600-11. PubMed ID: 16768612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.